SynthesisInternational urology and nephrology2022
Xanthogranulomatous pyelonephritis: a review and meta-analysis with a focus on management.
Synthesis in International urology and nephrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 20 citations in OpenAlex.
- Are Sellar Xanthogranulomas the Climax of a Spectrum of Secondary Inflammatory Reactions to Various Sellar Lesions?NeuroSci · 2026Article
- Disease complexity, not surgical approach, predicts outcomes in xanthogranulomatous pyelonephritis.Investigative and clinical urology · 2026Observational
- Laparoscopic nephrectomy for Xanthogranulomatous Pyelonephritis: First surgical outcomes report from Pakistan.Pakistan journal of medical sciences · 2026Article
- Xanthogranulomatous Pyelonephritis Presenting as Significant Hydronephrosis in an Adult Male Who Was Managed with Robotic-Assisted Radical Nephrectomy: A Case Report and Current Literature Review.Case reports in urology · 2026Article
- A Rare Case of Successful Conservative Treatment of an Extensive Xanthogranulomatous Pyelonephritis: Case Report and Review of the Literature.Clinical case reports · 2025Article
- Xanthogranulomatous pyelonephritis.Journal of nephrology · 2025Article
- A Rare Case of Bilateral Xanthogranulomatous Pyelonephritis Secondary to Candida albicans.Cureus · 2025Article
- Xanthogranulomatous Pyelonephritis in a Transplant Kidney Leading to Severe Allograft Dysfunction.Case reports in transplantation · 2025Article
- Stage III xanthogranulomatous pyelonephritis with sarcomatoid degeneration.Radiology case reports · 2024Article
- Xanthogranulomatous Pyelonephritis Mimicking a Complex Renal Cyst: A Report of a Rare Case.Cureus · 2024Article
- Systemic Amyloid A Amyloidosis Secondary to Xanthogranulomatous Pyelonephritis.Internal medicine (Tokyo, Japan) · 2024Article
- Fatal nephrobronchial fistula arising from xanthogranulomatous pyelonephritis: a case report.Frontiers in medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeXanthogranulomatous pyelonephritis (XGP) is a rare form of pyelonephritis more commonly seen in females and diabetics. Frequently associated with renal tract calculi, it is often difficult to diagnose, as it can clinically and radiologically mimic other disorders. Most cases are treated with antibiotics and nephrectomy. The aim of our review is to summarise and analyse the current evidence focusing on management.
methodsA literature search was conducted to identify papers relating to xanthogranulomatous pyelonephritis in adults. Studies containing ten or more patients with XGP were included for descriptive analysis, and a meta-analyses of cohort studies conducted comparing open and minimally invasive nephrectomy undertaken. Other papers were included for narrative review.
results52 studies were identified, 20 were included for narrative review and 32 retrospective observational studies containing 868 patients were included for descriptive analysis. 99.8% of patients underwent nephrectomy, about one-third laparoscopically. The most commonly cultured organisms were Escherichia coli and Proteus mirabilis. 60% of patients, where reported, underwent preoperative drainage. Seven studies containing 211 patients were included for meta-analysis which found that postoperative complications, length of stay and transfusion requirements were all significantly reduced in those who underwent minimally invasive surgery.
conclusionThe mainstay management of XGP is antibiotic therapy and nephrectomy. Some studies highlight a role for preoperative upper urinary tract drainage, but evidence supporting this is limited. We present the first meta-analyses examining operative approach for patients undergoing nephrectomy for XGP. Though limited by the data available, our meta-analysis indicates minimally invasive nephrectomy for XGP provides better postoperative outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.